As seasons change, temperatures rise and flowers begin to bloom, many find themselves battling more than just spring fever, ...

It's called Xolair, and the principal investigator said stage one of a three-stage study found 67% of people who got regular injections were able to tolerate a fairly large amount of peanut ...

Celldex (NASDAQ:CLDX) announced today new data demonstrating profound, sustained complete response and improved quality of life at 76 weeks, 7 months after the completion of dosing with barzolvolimab ...

Oklahomans should not have to fight their health insurer for the right to breathe. Blue Cross Blue Shield must abandon this ...

An example of specific endotyping in current clinical practice is the steps required to identify patients with difficult-to-control/severe asthma who qualify for omalizumab injections. This is ...

Delhi Police has busted a racket selling spurious anti-cancer drugs and arrested six men who targeted patients through social media by offering costly medicines at discounted rates, an official said ...

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 12.9% in a month. Teva’s stock mainly gained after it announced first-quarter 2025 results on May 7. Teva’s first-quarter results were ...

Results from a clinical trial show that giving people with high blood pressure an injection every six months can lead to a meaningful, sustained reduction in their blood pressure. Results from a ...

Researchers comparing two injections commonly used to relieve knee pain from osteoarthritis—corticosteroid and hyaluronic acid—found that corticosteroid injections were associated with higher ...

COLUMBIA, S.C. — South Carolina death row inmate Stephen Stanko on Friday chose to die by lethal injection after his lawyers said he was troubled by what appeared to be a lingering death of the ...

COLUMBIA, S.C. (AP/WCSC) - The next South Carolina death row inmate set to be executed has selected lethal injection as the method after his lawyers said he was troubled by the last execution by ...